How Long Is HSV-1 Contagious? A Timeline of Infection

HSV-1 is most contagious during an active outbreak, when sores are visible and actively shedding virus, but it can also spread when no symptoms are present at all. During a first infection, the virus sheds for an average of about 12 days, while recurrent episodes shed for a dramatically shorter window, roughly 13 hours on average.¹ That gap between first infection and recurrence is one of the most misunderstood aspects of HSV-1 contagion, and the role of invisible, asymptomatic shedding complicates the picture further.

What Happens During a First Infection

A primary HSV-1 infection is the body’s first encounter with the virus, and it tends to be the most aggressive. After exposure, there is an incubation period of several days before symptoms appear. Once sores develop, the virus actively replicates and sheds from those lesions. Women with a primary HSV infection shed the virus for an average of 12 days, compared with around 13 hours during a typical recurrence.¹ That nearly 12-day shedding window is the period when the virus is most actively leaving the body and most easily transmitted to someone else.

Primary infections also tend to cause the most noticeable symptoms: larger or more numerous sores, pain, swelling, and sometimes systemic symptoms like fever and fatigue. The immune system has never seen this virus before, so it takes time to mount a response. Full resolution of lesions during a first episode can take several weeks, depending on the location and the person’s immune status. During all of this time, the person should assume they are contagious.

Recurrent Cold Sores Are Much Shorter

After the initial infection, HSV-1 retreats into nerve cells and establishes a lifelong latent infection in sensory ganglia, most commonly the trigeminal ganglion near the base of the skull.² The virus sits dormant in these neurons without causing harm to the nerve cells themselves.³ Periodically, something triggers the virus to reactivate, travel back down the nerve, and produce a new outbreak at or near the original site of infection.

These recurrences are substantially milder and shorter than the first episode. Viral shedding during a recurrence averages only about 13 hours, a tiny fraction of the 12-day window during a primary infection.¹ The sores themselves typically heal in about a week. In one clinical study, the median time to full healing of recurrent cold sores was roughly seven to seven and a half days.⁴ But the key contagion insight is that most of the active virus leaves the body early, even though the sore sticks around longer as it crusts over and heals. The healing stages after crusting carry much less risk than the early weeping-blister stage.

Still, playing it safe means treating any visible cold sore as contagious until it is fully healed and the skin looks normal again. The crust that forms is not a perfect barrier, and virus can still be present under it.

Shedding Without Any Symptoms

Here is the part that surprises most people: HSV-1 can shed from the skin or mucous membranes even when there are no sores, no tingling, and no symptoms at all. This asymptomatic shedding is one of the main ways the virus spreads, because people have no idea they are contagious.

How often this happens depends partly on how you measure it. Older studies using viral culture found HSV-1 in oral samples on about 6% of days tested. But when researchers used more sensitive DNA detection methods, they found HSV-1 present in the mouth on about a third of days tested, and more than half of the people studied had detectable virus at multiple visits.⁵ The gap between these numbers reflects detection sensitivity: culture only picks up virus when there is enough to grow in a lab dish, while DNA-based tests catch smaller amounts that may or may not be enough to infect someone.

Individual variation is enormous. Some people in the oral shedding studies shed virus on zero percent of days, while others shed on over 90% of days.⁵ The typical shedding episode lasted one to three days, though about one in ten people shed for longer stretches. The upshot is that there is no safe day that you can confidently declare virus-free based on the absence of symptoms alone.

How Shedding Changes Over the First Year

If you recently acquired HSV-1, the first year is the most active period for shedding, and the rate drops noticeably as time goes on. A study tracking people with first-episode genital HSV-1 found that during an initial monitoring period within the first several months, about two-thirds of participants shed virus from the genital area, with shedding detected on roughly 12% of days overall. Most of that shedding was asymptomatic, occurring on about 11% of days without any visible lesions.⁶

By the second monitoring session later in the year, shedding had dropped. Only about a third of participants had detectable virus, and the overall shedding rate fell to around 7% of days.⁶ People who had a true primary infection (no prior antibodies to either herpes type) shed more frequently than those who already had some antibodies from a prior HSV-2 infection. So if you had never been exposed to any herpes virus before, your immune system took longer to bring shedding under control.

Oral shedding in the same study was less frequent throughout, detected on about 4% of days, with oral lesions rarely reported.⁶ This pattern suggests that genital HSV-1 is more active at the site of infection during the first year, while oral shedding remains relatively low even when the genital site was the primary one.

How Long Does the Virus Survive on Surfaces

People often worry about picking up HSV-1 from shared cups, towels, or surfaces. The virus does survive outside the body, but not for long. In studies using virus isolated from patients with active cold sores, HSV-1 survived for up to two hours on skin, three hours on cloth, and four hours on plastic.⁷ These are upper limits under laboratory conditions. In real-world settings with drying, temperature changes, and UV light, the virus likely dies faster.

This means fomite transmission (catching it from an object) is theoretically possible but much less common than direct skin-to-skin or mucous membrane contact. Sharing a lip balm with someone who has an active cold sore is riskier than using a doorknob they touched. The practical takeaway is that normal hygiene, not sharing personal items during outbreaks, and washing hands after touching sores are sensible precautions, but you do not need to sterilize your entire house.

What Triggers Reactivation

Understanding what wakes the virus up matters because reactivation is what creates new contagious windows. The triggers are varied, but a few are well documented. Physical stress on the nerve cells themselves appears to be a core mechanism. In laboratory models, heat stress reliably reactivates latent HSV-1 in neurons. The longer the heat exposure, the more likely reactivation becomes: a one-hour heat stress caused no reactivation, while a three-hour exposure triggered reactivation in about two-thirds of cultures.⁸

Capsaicin, the compound that makes chili peppers hot, activates the same heat-sensing channel on nerve cells (called VR-1) and also triggers reactivation in lab settings. The effect was dose-dependent, meaning more capsaicin led to more reactivation, and blocking the channel with an antagonist reduced it.⁹ This does not mean eating spicy food will give you a cold sore, since the capsaicin concentrations studied were applied directly to neurons in a dish. But it does help explain why fever, sunburn, and physical trauma to the face or lips are among the most commonly reported triggers in real life: they all stress the same sensory nerve pathways.

Other commonly reported triggers include illness, emotional stress, menstruation, fatigue, and UV exposure from sun or wind. The exact threshold differs wildly between people, which is part of why some HSV-1 carriers get frequent cold sores while others go years between episodes.

How Antivirals Change the Contagion Window

Antiviral medications do not eliminate HSV-1, but they meaningfully shorten both outbreaks and shedding. Topical treatments like acyclovir cream and docosanol primarily reduce how long a cold sore lasts and ease local symptoms when applied early in the outbreak. They have limited absorption into the body and do not reduce how often outbreaks happen.¹⁰

Systemic antivirals taken by mouth (acyclovir, valacyclovir, famciclovir) do more. They can shorten individual episodes and, when taken daily as suppressive therapy, reduce both the frequency of outbreaks and the amount of virus shed between outbreaks. Famciclovir, for instance, has been shown to cut healing time by about two days compared to no treatment.¹¹ In a study of suppressive therapy with valacyclovir (studied in people with HSV-2, where the drug works through the same mechanism), daily use reduced total viral shedding by about 78% and subclinical shedding by the same margin.¹² That is a substantial reduction, though it is not zero: breakthrough shedding still occurred on a small percentage of days.

The practical message is that antivirals compress the contagion timeline but do not close it entirely. If you take suppressive therapy, you shed far less virus far less often, which meaningfully lowers transmission risk. If you use episodic treatment at the first sign of a cold sore, you heal faster and probably shed for a shorter window. Neither approach makes you fully non-contagious.

Pregnancy and Neonatal Transmission

The contagion timeline takes on special urgency during pregnancy. About 85% of neonatal herpes infections happen during delivery, when the baby passes through a birth canal that is actively shedding virus.¹³ The risk is highest when a mother acquires a primary HSV infection in the third trimester, because her body has not yet had time to produce the antibodies that would help protect the baby.¹³

Women with recurrent herpes shed for a much shorter time (that average of 13 hours per recurrence), and their babies benefit from maternal antibodies that cross the placenta. The result is a dramatically lower transmission risk during recurrent episodes compared to a brand-new infection.¹⁴ Because many women with HSV shed asymptomatically and do not know they are infected, this remains a difficult problem to screen for and prevent.¹⁴

Spread Through Skin Contact in Sports

HSV-1 transmission is not limited to kissing or sexual contact. Any prolonged skin-to-skin contact with an area that is shedding virus can transmit infection. Wrestling provides one of the clearest examples. In a well-documented outbreak at a high-school wrestling camp, HSV-1 infection was diagnosed in 60 out of 175 wrestlers, an attack rate of 34%. Lesions appeared most often on the head, followed by the extremities and trunk, corresponding to the areas of greatest skin contact during matches.¹⁵

Constitutional symptoms were common in that outbreak. About a quarter of infected wrestlers had fever, and 40% had sore throats, suggesting many were experiencing primary infections. Five developed eye involvement, including conjunctivitis and blepharitis.¹⁶ Genetic analysis of the virus strains showed that different weight classes were circulating different strains, confirming person-to-person spread within each practice group rather than a single common source.¹⁵

This kind of outbreak illustrates how contagious HSV-1 can be when the right conditions align: close physical contact, broken skin from mat burns, and at least one person actively shedding virus. Most wrestling organizations now require skin checks and exclude athletes with active lesions, precisely because the attack rate can be so high in this environment.

People With Weakened Immune Systems

The timelines described above assume a functioning immune system. In people who are immunocompromised, whether from HIV, organ transplant drugs, chemotherapy, or other causes, HSV-1 outbreaks can look and behave quite differently. Lesions may be larger, last longer, appear in unusual locations, and shed virus for extended periods. These atypical presentations are easily misdiagnosed as something else entirely.¹⁷ For this group, the contagion window can be substantially longer than the averages that apply to otherwise healthy people, and suppressive antiviral therapy is more commonly recommended.

Why More Adults Are Getting Genital HSV-1

There is a slow but meaningful shift in HSV-1 epidemiology that changes who is at risk and how. In past decades, most people caught HSV-1 as children through casual contact, typically from family members. That childhood infection, while producing the occasional cold sore, also provided antibodies that offered partial protection against acquiring HSV-1 at a different body site later in life.

As hygiene standards have improved and household crowding has decreased in wealthier countries, fewer children are being exposed to HSV-1 before they become sexually active. The consequence is that more teenagers and young adults encounter HSV-1 for the first time through oral sex, leading to a genital HSV-1 infection rather than the traditional oral one.¹⁸ Paradoxically, early childhood exposure to HSV-1 can have a protective effect against sexually transmitted herpes later in life, because existing antibodies reduce the chance that HSV-1 will establish infection at a new site.¹⁹

This matters for the contagion timeline because genital HSV-1 has its own shedding profile. As the first-year shedding data showed, genital HSV-1 sheds frequently in the months after acquisition and then declines, but the early period is an active window when someone could unknowingly transmit the virus to a partner. The overall picture is one where a virus most people think of as “just cold sores” is increasingly showing up in genital infections, driven not by a change in the virus itself but by a shift in when and how people first encounter it.

Why Detection Methods Matter for Understanding Contagion

One wrinkle worth knowing about: the numbers around HSV-1 shedding depend heavily on how the virus is detected. Older studies relied on viral culture, which only catches episodes where enough live virus is present to grow in a lab. More sensitive DNA-based detection methods have revealed that shedding is far more common than culture ever suggested.²⁰ The oral shedding study mentioned earlier found virus on about 6% of days by culture but 33% of days by DNA testing.⁵

What does this mean for real-world contagion? Detecting viral DNA does not necessarily mean there is enough infectious virus present to transmit to another person. The true transmission risk on any given day of low-level shedding is probably somewhere between the culture number and the DNA number. Researchers still do not have a clean answer for what the minimum infectious dose is for HSV-1 in humans, so the precise cutoff remains unclear. The practical implication is that the older literature almost certainly underestimated how often people shed virus, but the newer PCR-based numbers may overestimate how often that shedding is actually dangerous to a partner. Reality sits somewhere in between, and that ambiguity is part of why HSV-1 transmission is so difficult to predict on an individual level.

1
PubMed Central. Genital Herpes Simplex Virus (HSV) Infection During Pregnancy – Recommendations of the Working Group on Obstetrics and Prenatal Medicine
2
PubMed Central. Olfactory and trigeminal routes of HSV-1 CNS infection with regional microglial heterogeneity
3
PubMed Central. Latent Herpes Simplex Virus 1 Infection Does Not Induce Apoptosis in Human Trigeminal Ganglia
4
PubMed. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis
5
PubMed. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity
6
JAMA. Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection
7
PubMed. Shedding and survival of herpes simplex virus from ‘fever blisters’
8
PubMed Central. Mechanisms of herpes simplex virus type 1 reactivation
9
PubMed. Capsaicin-induced reactivation of latent herpes simplex virus type 1 in sensory neurons in culture
10
PubMed Central. Topical and Systemic Therapeutic Approaches in the Treatment of Oral Herpes Simplex Virus Infection: A Systematic Review
11
Archives of Internal Medicine. The Treatment of Herpes Simplex Infections: An Evidence-Based Review
12
PubMed Central. Once Daily Valacyclovir for Reducing Viral Shedding in Subjects Newly Diagnosed with Genital Herpes
13
PubMed Central. Maternal-Fetal Implications of Herpes Virus Infection: An Updated Review
14
PubMed Central. Mother-to-Child Transmission of Herpes Simplex Virus
15
PubMed. An outbreak of herpes gladiatorum at a high-school wrestling camp
16
PubMed. Ocular involvement in an outbreak of herpes gladiatorum
17
PubMed Central. Atypical Presentation of Herpes Simplex Virus Infection in an Immunocompromised Patient
18
JAMA. Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
19
Journal of Infection. How Long Is HSV-1 Contagious? A Timeline of Infection
20
PubMed. HSV shedding